HRTG(HRTG)
HRTG
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $861M | $899M |
| Low | $855M | $893M |
| High | $867M | $905M |
| EBITDA Avg | $563M | $588M |
| Low | $559M | $584M |
| High | $567M | $592M |
| EBIT Avg | $553M | $577M |
| Low | $549M | $574M |
| High | $557M | $581M |
| Net Income Avg | $132M | $138M |
| Low | $130M | $129M |
| High | $140M | $164M |
| EPS Avg | $4.37 | $4.73 |
| Low | $4.19 | $4.17 |
| High | $4.54 | $5.29 |
| Analysts (Rev / EPS) | 1 / 2 | 1 / 2 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $217M | $219M | $220M | $222M | $227M | $230M |
| Low | $217M | $219M | $220M | $222M | $226M | $230M |
| High | $217M | $219M | $220M | $223M | $227M | $230M |
| EBITDA Avg | $142M | $143M | $144M | $145M | $148M | $151M |
| Low | $142M | $143M | $144M | $145M | $148M | $150M |
| High | $142M | $143M | $144M | $146M | $148M | $151M |
| EBIT Avg | $139M | $141M | $141M | $143M | $145M | $148M |
| Low | $139M | $140M | $141M | $143M | $145M | $148M |
| High | $139M | $141M | $141M | $143M | $146M | $148M |
| Net Income Avg | $18M | $40M | $38M | $39M | $19M | $46M |
| Low | $18M | $40M | $38M | $39M | $19M | $46M |
| High | $18M | $40M | $38M | $39M | $19M | $46M |
| EPS Avg | $0.61 | $1.32 | $1.27 | $1.29 | $0.63 | $1.53 |
| Low | $0.61 | $1.32 | $1.27 | $1.29 | $0.63 | $1.53 |
| High | $0.61 | $1.32 | $1.27 | $1.29 | $0.63 | $1.54 |
| Analysts (Rev / EPS) | 1 / 2 | 1 / 2 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |